Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
arhalofenate (1 trial)
pioglitazone (actos) (1 trial)
sitagliptin (januvia) (1 trial)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Trials (1 total)
Trial APIs (3 total)